Strs Ohio boosted its stake in shares of Zoetis Inc. (NYSE:ZTS) by 10.0% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 445,127 shares of the company’s stock after acquiring an additional 40,342 shares during the period. Strs Ohio owned 0.09% of Zoetis worth $28,381,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also modified their holdings of ZTS. BlackRock Inc. boosted its holdings in shares of Zoetis by 2,471.1% during the 1st quarter. BlackRock Inc. now owns 36,082,470 shares of the company’s stock valued at $1,925,722,000 after acquiring an additional 34,679,064 shares in the last quarter. Morgan Stanley lifted its holdings in Zoetis by 182.5% during the 1st quarter. Morgan Stanley now owns 14,617,205 shares of the company’s stock worth $780,119,000 after buying an additional 9,442,207 shares during the period. Janus Henderson Group PLC lifted its stake in shares of Zoetis by 7,717.4% in the 2nd quarter. Janus Henderson Group PLC now owns 5,809,086 shares of the company’s stock valued at $362,372,000 after purchasing an additional 5,734,776 shares during the period. Alliancebernstein L.P. lifted its stake in shares of Zoetis by 55.4% in the 2nd quarter. Alliancebernstein L.P. now owns 10,370,388 shares of the company’s stock valued at $646,905,000 after purchasing an additional 3,695,449 shares during the period. Finally, Waddell & Reed Financial Inc. lifted its stake in shares of Zoetis by 65.9% in the 1st quarter. Waddell & Reed Financial Inc. now owns 5,434,371 shares of the company’s stock valued at $290,033,000 after purchasing an additional 2,157,803 shares during the period. Institutional investors own 92.90% of the company’s stock.
A number of analysts recently commented on ZTS shares. BMO Capital Markets set a $65.00 target price on Zoetis and gave the company a “hold” rating in a research report on Wednesday, October 25th. BidaskClub raised Zoetis from a “buy” rating to a “strong-buy” rating in a report on Tuesday, September 12th. Cantor Fitzgerald reissued a “buy” rating and set a $75.00 price objective on shares of Zoetis in a report on Tuesday, October 24th. Deutsche Bank AG reissued a “buy” rating and set a $65.00 price objective (up from $62.00) on shares of Zoetis in a report on Monday, July 17th. Finally, Stifel Nicolaus reissued a “buy” rating and set a $65.00 price objective on shares of Zoetis in a report on Friday, September 1st. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and twelve have assigned a buy rating to the company. The stock presently has a consensus rating of “Buy” and an average target price of $67.06.
Zoetis Inc. (NYSE ZTS) traded down $0.17 during trading on Friday, hitting $69.13. 1,905,700 shares of the stock traded hands, compared to its average volume of 2,817,385. The company has a market capitalization of $33,769.08, a PE ratio of 31.79, a P/E/G ratio of 2.03 and a beta of 1.02. Zoetis Inc. has a 52-week low of $48.24 and a 52-week high of $70.48. The company has a current ratio of 2.80, a quick ratio of 1.95 and a debt-to-equity ratio of 2.45.
Zoetis (NYSE:ZTS) last released its earnings results on Thursday, November 2nd. The company reported $0.65 EPS for the quarter, beating the Zacks’ consensus estimate of $0.63 by $0.02. Zoetis had a return on equity of 62.39% and a net margin of 18.29%. The business had revenue of $1.35 billion for the quarter, compared to analysts’ expectations of $1.32 billion. During the same quarter in the prior year, the firm earned $0.52 earnings per share. The firm’s revenue was up 8.5% on a year-over-year basis. equities research analysts forecast that Zoetis Inc. will post 2.36 EPS for the current year.
The firm also recently announced a quarterly dividend, which will be paid on Friday, December 1st. Shareholders of record on Thursday, November 9th will be paid a dividend of $0.105 per share. This represents a $0.42 dividend on an annualized basis and a dividend yield of 0.61%. The ex-dividend date is Wednesday, November 8th. Zoetis’s dividend payout ratio is 22.11%.
WARNING: “Zoetis Inc. (ZTS) Holdings Boosted by Strs Ohio” was reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this piece of content on another site, it was copied illegally and republished in violation of US & international trademark & copyright law. The correct version of this piece of content can be viewed at https://www.dispatchtribunal.com/2017/11/11/zoetis-inc-zts-stake-boosted-by-strs-ohio.html.
Zoetis Company Profile
Zoetis Inc is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. The Company has a business, commercializing products across eight core species: cattle, swine, poultry, sheep and fish (collectively, livestock) and dogs, cats and horses (collectively, companion animals), and within five product categories: anti-infectives, vaccines, parasiticides, medicated feed additives and other pharmaceuticals.
Receive News & Ratings for Zoetis Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zoetis Inc. and related companies with MarketBeat.com's FREE daily email newsletter.